IJMS | Free Full-Text | Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease - ScienceDirect
NKF KDOQI Guidelines
Effect of Sevelamer on Calciprotein Particles in Hemodialysis Patients: The Sevelamer Versus Calcium to Reduce Fetuin-A-Containing Calciprotein Particles in Dialysis (SCaRF) Randomized Controlled Trial - ScienceDirect
Hyperphosphatemia Management in Patients with Chronic Kidney Disease - ScienceDirect
Daily OTC Pearl: Tums (Calcium Carbonate)
Aluminum Accumulation during Treatment with Aluminum Hydroxide and Dialysis in Children and Young Adults with Chronic Renal Disease | NEJM
PDF] Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients | Semantic Scholar
New Pharmacotherapy Options for Hyperphosphatemia
Frontiers | The Influence of Sevelamer Hydrochloride and Calcium Carbonate on Markers of Inflammation and Oxidative Stress in Hemodialysis at Six Months of Follow-Up
Remedying calcium and phosphate problems in chronic kidney disease - The Pharmaceutical Journal
Toxins | Free Full-Text | FGF23 and Phosphate–Cardiovascular Toxins in CKD